PetMed Express (PETS) Director James LaCamp Receives Award

What Happened James LaCamp, a director of PetMed Express, Inc. (PETS), was granted a restricted stock award of 55,555 shares on August 11, 2026. The shares were issued at $0.00 (no cash paid) — total immediate cash value reported as $0. The award was made under the PetMed Express, Inc. 2024 Omnibus Incentive Plan and vests in full on August 11, 2027, subject to continued service on the Board.

Key Details

• Transaction date: August 11, 2026; Form 4 filed August 12, 2026 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares granted: 55,555; price per share reported $0.00; total immediate cash value $0.
• Vesting/footnote: Award vests 100% on August 11, 2027 if director continues service (per Form 4 footnote).
• Shares owned after transaction: Not specified in the filing.
• No tax withholding, sale-to-cover, 10b5-1 plan, or late-filing issues reported.

Context This was a restricted stock award (compensation), not an open-market purchase or sale. Restricted grants typically vest over time and therefore do not immediately increase the insider’s liquid holdings; they reflect board compensation rather than an outright market bet. For investors, awards are routine executive/director compensation and should be viewed as informational rather than a direct buy/sell signal.